0.1268
price up icon6.11%   0.0073
after-market Handel nachbörslich: .12 -0.0068 -5.36%
loading

Petros Pharmaceuticals Inc Aktie (PTPI) Neueste Nachrichten

pulisher
May 06, 2025

Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform By Investing.com - Investing.com India

May 06, 2025
pulisher
May 06, 2025

Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform - Investing.com

May 06, 2025
pulisher
May 06, 2025

Petros Pharmaceuticals (PTPI) Boosts AI Platform with Advanced F - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - ACCESS Newswire

May 06, 2025
pulisher
May 06, 2025

Petros Pharma Upgrades AI Platform Following Trump Order to Expand OTC Drug Access - Stock Titan

May 06, 2025
pulisher
May 02, 2025

Petros Pharmaceuticals Announces Reverse Stock Split By Investing.com - Investing.com Australia

May 02, 2025
pulisher
May 02, 2025

Petros Pharmaceuticals Announces Reverse Stock Split - Investing.com

May 02, 2025
pulisher
May 02, 2025

Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - Asianet Newsable

May 02, 2025
pulisher
May 01, 2025

Petros Pharmaceuticals (PTPI) Aims to Transform with Innovative Healthcare Platform | PTPI Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Petros Pharmaceuticals pivots to smart healthcare tech By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Petros Pharmaceuticals pivots to smart healthcare tech - Investing.com

May 01, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Trump Healthcare Initiative Drives Petros Pharma's $38B AI Platform Innovation for OTC Drug Approvals - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

Petros Pharmaceuticals (PTPI) Aligns with Regulatory Climate Und - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider - ACCESS Newswire

Apr 30, 2025
pulisher
Apr 30, 2025

You might want to take a look at Petros Pharmaceuticals Inc (PTPI) now - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Trump Order To Improve Making More Drugs Available OTC Puts Wind Behind Petros’ ACNU Sails - insights.citeline.com

Apr 30, 2025
pulisher
Apr 29, 2025

Petros Pharmaceuticals gears up for Rx-to-OTC switch platform - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Petros Pharmaceuticals to effect 1-for-25 reverse stock split - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

PTPI Announces Reverse Stock Split at 1-for-25 Ratio | PTPI Stoc - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga

Apr 29, 2025
pulisher
Apr 29, 2025

Petros Pharmaceuticals gears up for Rx-to-OTC switch platform By Investing.com - Investing.com UK

Apr 29, 2025
pulisher
Apr 29, 2025

Trump Executive Order Validates Petros' AI Technology Platform for Revolutionary Drug Access Reform - Stock Titan

Apr 29, 2025
pulisher
Apr 29, 2025

Petros Pharmaceuticals (PTPI) Stock Soars 45% Over the Week - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Petros Pharmaceuticals (PTPI) Enhances Rx-to-OTC Platform with A - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

PTPI’s Stock Market Adventure: -79.26% YTD Growth Amidst Volatility - investchronicle.com

Apr 28, 2025
pulisher
Apr 28, 2025

PTPI Stock Plummets, But Premarket Hints at a Possible Rebound - Own Snap

Apr 28, 2025
pulisher
Apr 28, 2025

A stock that deserves closer examination: Petros Pharmaceuticals Inc (PTPI) - uspostnews.com

Apr 28, 2025
pulisher
Apr 25, 2025

Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 23, 2025

Petros Pharmaceuticals Inc (PTPI) can make a big difference with a little luck - Sete News

Apr 23, 2025
pulisher
Apr 21, 2025

Petros Pharmaceuticals stock hits 52-week low at $0.04 By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

Ratio Analysis: Unpacking Petros Pharmaceuticals Inc (PTPI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 21, 2025
pulisher
Apr 21, 2025

Petros Pharmaceuticals stock hits 52-week low at $0.04 - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Investing in Petros Pharmaceuticals Inc (PTPI) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - uspostnews.com

Apr 21, 2025
pulisher
Apr 14, 2025

Are Petros Pharmaceuticals Inc (PTPI) shares a good deal now? - uspostnews.com

Apr 14, 2025
pulisher
Apr 12, 2025

Petros Pharmaceuticals faces delisting, stockholders approve equity changes - Investing.com Australia

Apr 12, 2025
pulisher
Apr 11, 2025

Petros Pharmaceuticals faces delisting, stockholders approve equity changes By Investing.com - Investing.com Canada

Apr 11, 2025
pulisher
Apr 11, 2025

Petros Pharmaceuticals Approves Key Amendments to Incorporation - TipRanks

Apr 11, 2025
pulisher
Apr 09, 2025

Petros Pharmaceuticals appoints new auditor for 2025 By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Petros Pharmaceuticals appoints new auditor for 2025 - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

PTPI stock plunges to 52-week low of $0.05 amid market challenges - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

PTPI stock plunges to 52-week low of $0.05 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Petros Pharmaceuticals modifies terms with investors - MSN

Apr 08, 2025
pulisher
Apr 07, 2025

A closer look at Petros Pharmaceuticals Inc (PTPI)’s stock price trends - uspostnews.com

Apr 07, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
$30.84
price down icon 1.38%
$78.95
price down icon 0.72%
$8.79
price down icon 1.90%
$116.87
price down icon 2.96%
drug_manufacturers_specialty_generic RDY
$14.10
price up icon 1.22%
$308.07
price down icon 0.88%
Kapitalisierung:     |  Volumen (24h):